Stock Alert: Aurobindo Pharma, Akums Drugs, Vadilal Inds, Awfis Space Solutions

Image
Last Updated : May 27 2025 | 9:16 AM IST
Securities in F&O Ban:

Chambal Fertilisers & Chemicals, Hindustan Copper, Manappuram Finance, RBL Bank and Titagarh Rail Systems are banned from F&O trading on 27 May 2025.

Upcoming Results:

Life Insurance Corporation of India, Bharat Dynamics, Bosch, DCX Systems, Dynamatic Technologies, EID Parry India, Entero Healthcare Solutions, Esab India, Gujarat Fluorochemicals, Gateway Distriparks, Goodyear India, Hindustan Copper, ITI, JK Lakshmi Cement, Medplus Health Services, Minda Corporation, Info Edge (India), NMDC, V2 Retail will declare their results later today.

Stocks to Watch:

Aurobindo Pharmas consolidated net profit fell 0.6% to Rs 903.47 crore despite of 11.9% increase in net sales to Rs 8,381.12 crore in Q4 FY25 over Q4 FY24.

Akums Drugs & Pharmaceuticals reported consolidated net profit of Rs 147.62 crore in Q4 FY25 as compared with net loss of Rs 41.32 crore in Q4 FY24. Net sales jumped 11.8% YoY to Rs 1,055.55 crore in Q4 FY25.

Vadilal Industries consolidated net profit declined 20.4% to Rs 22 crore in Q4 FY25 from Rs 27.64 crore in Q4 FY24. Net sales rose 9.2% YoY to Rs 274.47 crore during the quarter ended 31st March 2025.

Orchid Pharma reported a 32.4% decline in consolidated net profit to Rs 22.29 crore in Q4 FY25 as compared with Rs 32.96 crore in Q4 FY24. Net sales increased 9.4% YoY to Rs 237.48 crore in Q4 FY25.

Awfis Space Solutions consolidated net profit soared 713.8% to Rs 11.23 crore on 46.2% increase in net sales to Rs 339.69 crore in Q4 FY25 over Q4 FY24.

Olectra Greentech reported a 53.2% increase in consolidated net profit to Rs 21 crore on 55.4% rise in net sales to Rs 448.92 crore in Q4 FY25 over Q4 FY24.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 27 2025 | 8:07 AM IST

Next Story